Pathobiology of Ischemic Heart Disease: Past, Present and Future

Cardiovascular Pathology

Volumn 25, Issue 3, 2016, Pages 214-220

  Buja, L Maximilian ^a   Vander Heide, Richard S ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hibernation; Mitochondria; Myocardial infarction; Myocardial ischemia; Postconditioning; Preconditioning; Stunning

Indexed keywords

ARTICLE; CARDIOVASCULAR MORTALITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY REPERFUSION; FIBRINOLYTIC THERAPY; HEART ELECTROPHYSIOLOGY; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; MORBIDITY; MULTICENTER STUDY (TOPIC); MYOCARDIAL HIBERNATION; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REPERFUSION INJURY; STEM CELL TRANSPLANTATION; STUNNED HEART MUSCLE; TISSUE REGENERATION; TRANSLUMINAL CORONARY ANGIOPLASTY; CARDIOLOGY; PROCEDURES; TRENDS;

CARDIOLOGY; HUMANS; MYOCARDIAL ISCHEMIA;

EID: 84959319869     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2016.01.007     Document Type: Review

References (122)

1. TA Gaziano, and JM Gaziano Global burden of cardiovascular disease R.O. Bonow, D.L. Mann, D.P. Zipes, P. Libby, Braunwald's heart disease: a textbook of cardiovascular medicine 9th ed. 2012 Elsevier/Saunders Philadelphia 1 20
2. J Ma, EM Ward, RL Siegel, and A Jemal Temporal trends in mortality in the United States, 1969-2013 JAMA 314 16 2015 1731 1739 10.1001/jama.2015.12319
3. G Thiene, and C Basso Myocardial infarction: A paradigm of success in modern medicine Cardiovasc Pathol 19 1 2010 1 5 10.1016/j.carpath.2009.08.002
4. MB Furie, and RN Mitchell Plaque attack: one hundred years of atherosclerosis in the American journal of pathology Am J Pathol 180 6 2012 2184 2187 10.1016/j.ajpath.2012.04.003 [Accessed 21 October 2015]
5. MC Fishbein, and GA Fishbein Arteriosclerosis: facts and fancy Cardiovasc Pathol 2015 [doi: S1054-8807(15)00084-8 [pii]]
6. S Glagov, E Weisenberg, CK Zarins, R Stankunavicius, and GJ Kolettis Compensatory enlargement of human atherosclerotic coronary arteries N Engl J Med 316 22 1987 1371 1375 10.1056/NEJM198705283162204
7. S Glagov, HS Bassiouny, Y Sakaguchi, CA Goudet, and RP Vito Mechanical determinants of plaque modeling, remodeling and disruption Atherosclerosis 131 Suppl 1997 S13 S14 [doi: S0021-9150(97)06117-0 [pii]]
8. MJ Davies, N Woolf, and WB Robertson Pathology of acute myocardial infarction with particular reference to occlusive coronary thrombi Br Heart J 38 7 1976 659 664
9. MJ Davies, and A Thomas Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death N Engl J Med 310 18 1984 1137 1140 10.1056/NEJM198405033101801
10. LM Buja, and JT Willerson The role of coronary artery lesions in ischemic heart disease: insights from recent clinicopathologic, coronary arteriographic, and experimental studies Hum Pathol 18 5 1987 451 461
11. MC Fishbein The vulnerable and unstable atherosclerotic plaque Cardiovasc Pathol 19 1 2010 6 11 10.1016/j.carpath.2008.08.004
12. R Heo, R Nakazato, D Kalra, and JK Min Noninvasive imaging in coronary artery disease Semin Nucl Med 44 5 2014 398 409 10.1053/j.semnuclmed.2014.05.004
13. AJ Brown, DR Obaid, C Costopoulos, and et al. Direct comparison of virtual-histology intravascular ultrasound and optical coherence tomography imaging for identification of thin-cap fibroatheroma Circ Cardiovasc Imaging 8 10 2015 e003487 10.1166.61/CIRCIMAGING.115.003487
14. AB Weisse The elusive clot: the controversy over coronary thrombosis in myocardial infarction J Hist Med Allied Sci 61 1 2006 66 78 [doi: jrj003 [pii]]
15. MA DeWood, J Spores, R Notske, and et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction N Engl J Med 303 16 1980 897 902 10.1056/NEJM198010163031601
16. A Carol, M Bernet, A Curos, and et al. Thrombus age, clinical presentation, and reperfusion grade in myocardial infarction Cardiovasc Pathol 23 3 2014 126 130 10.1016/j.carpath.2014.01.007
17. I Steiner, J Spacek, A Matejkova, J Vojacek, J Bis, and J Dusek Histopathology of aspirated thrombi during primary percutaneous coronary intervention in patients with acute myocardial infarction Cardiovasc Pathol 23 5 2014 267 271 10.1016/j.carpath.2014.04.006
18. X Li, OJ de Boer, H Ploegmaker, and et al. Granulocytes in coronary thrombus evolution after myocardial infarction - time-dependent changes in expression of matrix metalloproteinases Cardiovasc Pathol 2015 [doi: S1054-8807(15)00118-0 [pii]]
19. LM Buja, and JT Willerson Relationship of ischemic heart disease to sudden death J Forensic Sci 36 1991 25 33
20. JE Saffitz The pathology of sudden cardiac death in patients with ischemic heart disease-arrhythmology for anatomic pathologists Cardiovasc Pathol 14 4 2005 195 203 [doi: S1054-8807(05)00063-3 [pii]]
21. J Saffitz, and D Corradi The electrical heart: 25 years of discovery in cardiac electrophysiology, arrhythmias and sudden death Cardiovasc Pathol 2016 [in press]
22. JD Folts, EB Crowell, and GG Rowe Platelet aggregation in partially obstructed vessels and its elimination with aspirin Circulation 54 3 1976 365 370
23. LR Bush, WB Campbell, LM Buja, GD Tilton, and JT Willerson Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries Circulation 69 6 1984 1161 1170
24. P Libby Mechanisms of acute coronary syndromes and their implications for therapy N Engl J Med 368 21 2013 2004 2013 10.1056/NEJMra1216063
25. A Arbab-Zadeh, and V Fuster The myth of the "vulnerable plaque": Transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment J Am Coll Cardiol 65 8 2015 846 855 10.1016/j.jacc.2014.11.041
26. E Falk, M Nakano, JF Bentzon, AV Finn, and R Virmani Update on acute coronary syndromes: the pathologists' view Eur Heart J 34 10 2013 719 728 10.1093/eurheartj/ehs411
27. JF Bentzon, F Otsuka, R Virmani, and E Falk Mechanisms of plaque formation and rupture Circ Res 114 12 2014 1852 1866 10.1161/CIRCRESAHA.114.302721
28. RB Jennings, HM Sommers, GA Smyth, HA Flack, and H Linn Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog Arch Pathol 70 1960 68 78
29. RA Kloner, CE Ganote, and RB Jennings The "no-reflow" phenomenon after temporary coronary occlusion in the dog J Clin Invest 54 6 1974 1496 1508 10.1172/JCI107898
30. RB Jennings, and KA Reimer Lethal myocardial ischemic injury Am J Pathol 102 2 1981 241 255
31. RB Jennings, and KA Reimer The cell biology of acute myocardial ischemia Annu Rev Med 42 1991 225 246 10.1146/annurev.me.42.020191.001301
32. JL Farber, KR Chien, and S Mittnacht Myocardial ischemia: the pathogenesis of irreversible cell injury in ischemia Am J Pathol 102 2 1981 271 281
33. LM Buja, ML Eigenbrodt, and EH Eigenbrodt Apoptosis and necrosis. Basic types and mechanisms of cell death Arch Pathol Lab Med 117 12 1993 1208 1214
34. KA Reimer, JE Lowe, MM Rasmussen, and RB Jennings The wavefront phenomenon of ischemic cell death. I. myocardial infarct size vs duration of coronary occlusion in dogs Circulation 56 5 1977 786 794
35. KA Reimer, and RB Jennings The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow Lab Investig 40 6 1979 633 644
36. G Majno, and I Joris Apotosis, oncosis and necrosis. An overview of cell death Am J Pathol 146 1995 3 15
37. P Weerasinghe, and LM Buja Oncosis: An important non-apoptotic mode of cell death Exp Mol Pathol 93 3 2012 302 308 10.1016/j.yexmp.2012.09.018
38. P Weerasinghe, S Hallock, RE Brown, DS Loose, and LM Buja A model for cardiomyocyte cell death: Insights into mechanisms of oncosis Exp Mol Pathol 94 1 2013 289 300 10.1016/j.yexmp.2012.04.022
39. RA Gottlieb, KO Burleson, RA Kloner, BM Babior, and RL Engler Reperfusion injury induces apoptosis in rabbit cardiomyocytes J Clin Invest 94 4 1994 1621 1628 10.1172/JCI117504
40. J Xiao, GR Krueger, LM Buja, and M Covinsky The impact of declining clinical autopsy: Need for revised healthcare policy Am J Med Sci 337 1 2009 41 46 10.1097/MAJ.0b013e318184ce2b
41. F Zampieri, S Rizzo, G Thiene, and C Basso The clinico-pathological conference, based upon Giovanni Battista Morgagni's legacy, remains of fundamental importance even in the era of the vanishing autopsy Virchows Arch 467 3 2015 249 254 10.1007/s00428-015-1785-9
42. DL Page, JB Caulfield, JA Kastor, RW DeSanctis, and CA Sanders Myocardial changes associated with cardiogenic shock N Engl J Med 285 3 1971 133 137 10.1056/NEJM197107152850301
43. DR Alonso, S Scheidt, M Post, and T Killip Pathophysiology of cardiogenic shock. Quantification of myocardial necrosis, clinical, pathologic and electrocardiographic correlations Circulation 48 3 1973 588 596
44. LM Buja, RW Parkey, EM Stokely, FJ Bonte, and JT Willerson Pathophysiology of technetium-99 m stannous pyrophosphate and thallium-201 scintigraphy of acute anterior myocardial infarcts in dogs J Clin Invest 57 6 1976 1508 1522 10.1172/JCI108421
45. LM Buja, AJ Tofe, PV Kulkarni, and et al. Sites and mechanisms of localization of technetium-99 m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues J Clin Invest 60 3 1977 724 740 10.1172/JCI108825
46. S Al Sayari, S Kopp, and J Bremerich Stress cardiac MR imaging: The role of stress functional assessment and perfusion imaging in the evaluation of ischemic heart disease Radiol Clin N Am 53 2 2015 355 367 10.1016/j.rcl.2014.11.006
47. H Engblom, AH Aletras, E Heiberg, H Arheden, and M Carlsson Quantification of myocardial salvage by myocardial perfusion SPECT and cardiac magnetic resonance-reference standards for ECG development J Electrocardiol 47 4 2014 525 534 10.1016/j.jelectrocard.2014.04.001
48. LM Buja, and D Vela Cardiomyocyte death and renewal in the normal and diseased heart Cardiovasc Pathol 17 6 2008 349 374 10.1016/j.carpath.2008.02.004
49. H Suma, and AC Anyanwu Current status of surgical ventricular restoration for ischemic cardiomyopathy Semin Thorac Cardiovasc Surg 24 4 2012 294 301 10.1053/j.semtcvs.2013.01.002
50. G Ottaviani, R Radovancevic, B Kar, I Gregoric, and LM Buja Pathological assessment of end-stage heart failure in explanted hearts in correlation with hemodynamics in patients undergoing orthotopic heart transplantation Cardiovasc Pathol 24 5 2015 283 289 10.1016/j.carpath.2015.06.002
51. E Braunwald, and PR Maroko The reduction of infarct size-an idea whose time (for testing) has come Circulation 50 2 1974 206 209
52. LG Lange, and BE Sobel Pharmacological salvage of myocardium Annu Rev Pharmacol Toxicol 22 1982 115 143 10.1146/annurev.pa.22.040182.000555
53. KA Reimer, and RB Jennings The changing anatomic reference base of evolving myocardial infarction. Underestimation of myocardial collateral blood flow and overestimation of experimental anatomic infarct size due to tissue edema, hemorrhage and acute inflammation Circulation 60 4 1979 866 876
54. KA Reimer, RB Jennings, FR Cobb, and et al. Animal models for protecting ischemic myocardium: results of the NHLBI cooperative study: comparison of unconscious and conscious dog models Circ Res 56 5 1985 651 665
55. KA Reimer, and RB Jennings Biologic basis for limitation of infarct size Adv Exp Med Biol 194 1986 315 330
56. D Glogar, P Yang, and G Steurer Management of acute myocardial infarction: evaluating the past, practicing in the present, elaborating the future Am Heart J 132 2 Pt 2 Su 1996 465 470 [discussion 496-502]
57. E Braunwald, and RA Kloner Myocardial reperfusion: a double-edged sword? J Clin Invest 76 5 1985 1713 1719 10.1172/JCI112160
58. LM Buja Modulation of the myocardial response to ischemia Lab Investig 78 11 1998 1345 1373
59. LM Buja Myocardial ischemia and reperfusion injury Cardiovasc Pathol 14 4 2005 170 175 doi: S163.054-8807(05)00056-6 [pii]
60. DM Yellon, and DJ Hausenloy Myocardial reperfusion injury N Engl J Med 357 11 2007 1121 1135 [doi: 357/11/1121 [pii]]
61. LM Buja, and P Weerasinghe Unresolved issues in myocardial reperfusion injury Cardiovasc Pathol 19 1 2010 29 35 10.1016/j.carpath.2008.10.001
62. GV Moukarbel, CM Ayoub, and AB Abchee Pharmacological therapy for myocardial reperfusion injury Curr Opin Pharmacol 4 2 2004 147 153 10.1016/j.coph.2003.10.012
63. C Basso, S Rizzo, and G Thiene The metamorphosis of myocardial infarction following coronary recanalization Cardiovasc Pathol 19 1 2010 22 28 10.1016/j.carpath.2009.06.010
64. SJ Head, TM Kieser, V Falk, HA Huysmans, and AP Kappetein Coronary artery bypass grafting: part 1-the evolution over the first 50 years Eur Heart J 34 37 2013 2862 2872 10.1093/eurheartj/eht330
65. SJ Head, J Borgermann, RL Osnabrugge, and et al. Coronary artery bypass grafting: part 2-optimizing outcomes and future prospects Eur Heart J 34 37 2013 2873 2886 10.1093/eurheartj/eht284
66. M Diodato, and EG Chedrawy Coronary artery bypass graft surgery: the past, present, and future of myocardial revascularisation Surg Res Pract 2014 2014 726158 10.1155/2014/726158
67. Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. gruppo italiano per lo studio della streptochinasi nell'infarto miocardico (GISSI) Lancet 1 8478 1986 397 402
68. E Braunwald, and MS Sabatine The thrombolysis in myocardial infarction (TIMI) study group experience J Thorac Cardiovasc Surg 144 4 2012 762 770 10.1016/j.jtcvs.2012.07.001
69. AR Gruntzig, A Senning, and WE Siegenthaler Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty N Engl J Med 301 2 1979 61 68 10.1056/NEJM197907123010201
70. LM Buja Vascular responses to percutaneous coronary intervention with bare-metal stents and drug-eluting stents: a perspective based on insights from pathological and clinical studies J Am Coll Cardiol 57 11 2011 1323 1326 10.1016/j.jacc.2010.11.033
71. K Steigerwald, S Ballke, SC Quee, and et al. Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation EuroIntervention 8 6 2012 752 759 10.4244/EIJV8I6A115
72. C Chaabane, F Otsuka, R Virmani, and ML Bochaton-Piallat Biological responses in stented arteries Cardiovasc Res 99 2 2013 353 363 10.1093/cvr/cvt115
73. K Yahagi, FD Kolodgie, F Otsuka, and et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis Nat Rev Cardiol 2015 10.1038/nrcardio.2015.164
74. SP Sedlis, PM Hartigan, KK Teo, and et al. Effect of PCI on long-term survival in patients with stable ischemic heart disease N Engl J Med 373 20 2015 1937 1946 10.1056/NEJMoa1505532
75. GR Heyndrickx, H Baig, P Nellens, I Leusen, MC Fishbein, and SF Vatner Depression of regional blood flow and wall thickening after brief coronary occlusions Am J Phys 234 6 1978 H653 H659
76. E Braunwald, and RA Kloner The stunned myocardium: prolonged, postischemic ventricular dysfunction Circulation 66 6 1982 1146 1149
77. B Patel, RA Kloner, K Przyklenk, and E Braunwald Postischemic myocardial "stunning": a clinically relevant phenomenon Ann Intern Med 108 4 1988 626 628
78. R Bolli, BS Patel, MO Jeroudi, EK Lai, and PB McCay Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone J Clin Invest 82 2 1988 476 485 10.1172/JCI113621
79. C Chen, J Liu, D Hua, and et al. Impact of delayed reperfusion of myocardial hibernation on myocardial ultrastructure and function and their recoveries after reperfusion in a pig model of myocardial hibernation Cardiovasc Pathol 9 2 2000 67 84 [doi: S1054-8807(00)00029-6 [pii]]
80. T Lai, JT Fallon, J Liu, and et al. Reversibility and pathohistological basis of left ventricular remodeling in hibernating myocardium Cardiovasc Pathol 9 6 2000 323 335 [doi: S1054-8807(00)00052-1 [pii]]
81. C Depre, and SF Vatner Cardioprotection in stunned and hibernating myocardium Heart Fail Rev 12 3-4 2007 307 317 10.1007/s10741-007-9040-3
82. BN Shah, RS Khattar, and R Senior The hibernating myocardium: current concepts, diagnostic dilemmas, and clinical challenges in the post-STICH era Eur Heart J 34 18 2013 1323 1336 10.1093/eurheartj/eht018
83. CE Murry, RB Jennings, and KA Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 5 1986 1124 1136
84. KA Reimer, CE Murry, and RB Jennings Cardiac adaptation to ischemia: ischemic preconditioning increases myocardial tolerance to subsequent ischemic episodes Circulation 82 6 1990 2266 2268
85. CE Murry, VJ Richard, KA Reimer, and RB Jennings Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode Circ Res 66 4 1990 913 931
86. M Matsuda, TG Catena, RS Vander Heide, RB Jennings, and KA Reimer Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning Cardiovasc Res 27 4 1993 585 592
87. KA Reimer, and RB Jennings Ischemic preconditioning: a brief review Basic Res Cardiol 91 1 1996 1 4
88. DM Yellon, and JM Downey Preconditioning the myocardium: from cellular physiology to clinical cardiology Physiol Rev 83 4 2003 1113 1151 10.1152/physrev.00009.2003
89. RA Kloner, R Bolli, E Marban, L Reinlib, and E Braunwald Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop Circulation 97 18 1998 1848 1867
90. X Yang, MV Cohen, and JM Downey Mechanism of cardioprotection by early ischemic preconditioning Cardiovasc Drugs Ther 24 3 2010 225 234 10.1007/s10557-010-6236-x
91. MV Cohen, and JM Downey Ischemic postconditioning: from receptor to end-effector Antioxid Redox Signal 14 5 2011 821 831 10.1089/ars.2010.3318
92. G Heusch, HE Botker, K Przyklenk, A Redington, and D Yellon Remote ischemic conditioning J Am Coll Cardiol 65 2 2015 177 195 10.1016/j.jacc.2014.10.031
93. RS Vander Heide, ML Hill, KA Reimer, and RB Jennings Effect of reversible ischemia on the activity of the mitochondrial ATPase: relationship to ischemic preconditioning J Mol Cell Cardiol 28 1 1996 103 112 doi: S0022-2828(96)90010-3 [pii]
94. T Krieg, MV Cohen, and JM Downey Mitochondria and their role in preconditioning's trigger phase Basic Res Cardiol 98 4 2003 228 234
95. AV Kristen, K Ackermann, S Buss, and et al. Inhibition of apoptosis by the intrinsic but not the extrinsic apoptotic pathway in myocardial ischemia-reperfusion Cardiovasc Pathol 22 4 2013 280 286 10.1016/j.carpath.2013.01.004
96. LM Buja The pathobiology of acute coronary syndromes: clinical implications and central role of the mitochondria Tex Heart Inst J 40 2013 221 228
97. A Skyschally, S Gent, G Amanakis, C Schulte, P Kleinbongard, and G Heusch Across -species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by reperfusion injury salvage kinase and survival activating factor enhancement pathways Circ Res 117 3 2015 279 288 10.1161/CIRCRESAHA.117.306878
98. Heide R Vander Clinically useful cardioprotection: Ischemic preconditioning then and now J Cardiovasc Pharmacol Ther 16 3-4 2011 251 254 10.1177/1074248411407070
99. RS Vander Heide, and C Steenbergen Cardioprotection and myocardial reperfusion: pitfalls to clinical application Circ Res 113 4 2013 464 477 10.1161/CIRCRESAHA.113.300765
100. GM Frohlich, P Meier, SK White, DM Yellon, and DJ Hausenloy Myocardial reperfusion injury: looking beyond primary PCI Eur Heart J 34 23 2013 1714 1722 10.1093/eurheartj/eht090
101. AJ Perricone, and RS Vander Heide Novel therapeutic strategies for ischemic heart disease Pharmacol Res 89 2014 36 45 10.1016/j.phrs.2014.08.004
102. G Heusch Molecular basis of cardioprotection: Signal transduction in ischemic pre-, post-, and remote conditioning Circ Res 116 4 2015 674 699 10.1161/CIRCRESAHA.116.305348
103. B Ibanez, G Heusch, M Ovize, and F Van de Werf Evolving therapies for myocardial ischemia/reperfusion injury J Am Coll Cardiol 65 14 2015 1454 1471 10.1016/j.jacc.2015.02.032
104. C Piot, P Croisille, P Staat, and et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction N Engl J Med 359 5 2008 473 481 10.1056/NEJMoa071142
105. RA Kloner, and Longacre L Schwartz State of the science of cardioprotection: challenges and opportunities-proceedings of the 2010 NHLBI workshop on cardioprotection J Cardiovasc Pharmacol Ther 16 3-4 2011 223 232 10.1177/1074248411402501
106. L Schwartz Longacre, RA Kloner, AE Arai, and et al. New horizons in cardioprotection: recommendations from the 2010 national heart, lung, and blood institute workshop Circulation 124 10 2011 1172 1179 10.1161/CIRCULATIONAHA.111.032698
107. DJ Lefer, and R Bolli Development of an NIH consortium for preclinicAl AssESsment of CARdioprotective therapies (CAESAR): a paradigm shift in studies of infarct size limitation J Cardiovasc Pharmacol Ther 16 3-4 2011 332 339 10.1177/1074248411414155
108. TT Cung, O Morel, G Cayla, and et al. Cyclosporine before PCI in patients with acute myocardial infarction N Engl J Med 373 11 2015 1021 1031 10.1056/NEJMoa1505489
109. DJ Hausenloy, R Kharbanda, M Rahbek Schmidt, and et al. Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Eur Heart J 36 29 2015 1846 1848
110. P Meybohm, B Bein, O Brosteanu, and et al. A multicenter trial of remote ischemic preconditioning for heart surgery N Engl J Med 373 15 2015 1397 1407 10.1056/NEJMoa1413579
111. DJ Hausenloy, L Candilio, R Evans, and et al. Remote ischemic preconditioning and outcomes of cardiac surgery N Engl J Med 373 15 2015 1408 1417 10.1056/NEJMoa1413534
112. M Zaugg, and E Lucchinetti Remote ischemic preconditioning in cardiac surgery-ineffective and risky? N Engl J Med 373 15 2015 1470 1472 10.1056/NEJMe1510338
113. H Bulluck, DM Yellon, and DJ Hausenloy Reducing myocardial infarct size: challenges and future opportunities Heart 2015 10.1136/heartjnl-2015307855 [Dec 16. pii: heartjnl-2015-307855. [Epub ahead of print]. Myocardial Repair and Regeneration (also see reference 48)]
114. LM Buja, and D Vela Current status of the role of stem cells in myocardial biology and repair Cardiovasc Pathol 20 5 2011 297 301 10.1016/j.carpath.2010.08.004
115. LM Buja, and D Vela Immunologic and inflammatory reactions to exogenous stem cells implications for experimental studies and clinical trials for myocardial repair J Am Coll Cardiol 56 21 2010 1693 1700 10.1016/j.jacc.2010.06.041
116. KA Gerbin, and CE Murry The winding road to regenerating the human heart Cardiovasc Pathol 24 3 2015 133 140 10.1016/j.carpath.2015.02.004
117. MR Rosen, RJ Myerburg, DP Francis, GD Cole, and E Marban Translating stem cell research to cardiac disease therapies: pitfalls and prospects for improvement J Am Coll Cardiol 64 9 2014 922 937 10.1016/j.jacc.2014.06.1175
118. SA Fisher, SJ Brunskill, C Doree, A Mathur, DP Taggart, and E Martin-Rendon Stem cell therapy for chronic ischaemic heart disease and congestive heart failure Cochrane Database Syst Rev 4 2014 CD007888 10.1002/14651858.CD007888.pub2
119. SA Fisher, C Doree, A Mathur, and E Martin-Rendon Meta-analysis of cell therapy trials for patients with heart failure Circ Res 116 8 2015 1361 1377 10.1161/CIRCRESAHA.116.304386
120. SA Fisher, H Zhang, C Doree, A Mathur, and E Martin-Rendon Stem cell treatment for acute myocardial infarction Cochrane Database Syst Rev 9 2015 CD006536 10.1002/14651858.CD006536.pub4
121. K Wei, V Serpooshan, C Hurtado, and et al. Epicardial FSTL1 reconstitution regenerates the adult mammalian heart Nature 525 7570 2015 479 485 10.1038/nature15372
122. E van Rooij Cardiac repair after myocardial infarction N Engl J Med 374 1 2016 85 87 10.1056/NEJMcibr1512011